Harvard Bioscience (HBIO) – Press Releases
-
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
-
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
-
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
-
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
-
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
-
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
-
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
-
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
-
Harvard Bioscience Announces Third Quarter 2023 Financial Results
-
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
-
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
-
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
-
Harvard Bioscience Announces Second Quarter 2023 Financial Results
-
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
-
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
-
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
-
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
-
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
-
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
-
Harvard Bioscience Announces First Quarter 2023 Financial Results
-
Harvard Bioscience Announces First Quarter 2023 Financial Results
-
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
-
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
-
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
-
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
-
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
-
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
-
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
-
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
-
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
-
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
-
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
-
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
-
Harvard Bioscience Announces CFO Transition
-
Harvard Bioscience Announces CFO Transition
-
Harvard Bioscience Announces Third Quarter 2022 Financial Results
-
Harvard Bioscience Announces Third Quarter 2022 Financial Results
-
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
-
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
-
Harvard Bioscience Announces Second Quarter 2022 Financial Results
-
Harvard Bioscience Announces Second Quarter 2022 Financial Results
-
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
-
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
-
Harvard Bioscience Announces First Quarter 2022 Financial Results
-
Harvard Bioscience Announces First Quarter 2022 Financial Results
-
Aldeyra Therapeutics Announces Chief Financial Officer Transition
-
Harvard Bioscience Introduces SmartStudy™: First of Kind, Next Generation Inhalation System Capability Improves Precision and Drives Growth
-
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
-
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
-
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
Back to HBIO Stock Lookup